reviewJournal of Clinical InvestigationSep 4, 2012GREEN OA

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

University of Massachusetts Chan Medical School · Semmelweis University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Alcoholic liver disease (ALD) is characterized by steatosis and upregulation of proinflammatory cytokines, including IL-1β. IL-1β, type I IL-1 receptor (IL-1R1), and IL-1 receptor antagonist (IL-1Ra) are all important regulators of the IL-1 signaling complex, which plays a role in inflammation. Furthermore, IL-1β maturation is dependent on caspase-1 (Casp-1). Using IL-1Ra-treated mice as well as 3 mouse models deficient in regulators of IL-1β activation (Casp-1 and ASC) or signaling (IL-1R1), we found that IL-1β signaling is required for the development of alcohol-induced liver steatosis, inflammation, and injury. Increased IL-1β was due to upregulation of Casp-1 activity and inflammasome activation. The…

Citation impact

732
total citations
FWCI
28.09
Percentile
100%
References
41
Citations per year

Authors

10

Topics & keywords

Keywords
  • Inflammasome
  • Downregulation and upregulation
  • Proinflammatory cytokine
  • Inflammation
  • Steatosis
  • Steatohepatitis
  • CASP
  • Fatty liver
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding